These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15231861)

  • 61. Folinic acid (CF)/5-fluorouracil (FUra) combinations in advanced gastrointestinal carcinomas.
    Wilke H; Schmoll HJ; Preusser P; Fink U; Stahl M; Schöber C; Link H; Freund M; Hanauske A; Meyer HJ
    Adv Exp Med Biol; 1988; 244():233-43. PubMed ID: 3073658
    [No Abstract]   [Full Text] [Related]  

  • 62. Is Electrocardiogram Helpful in Predicting a Rise in Troponin I as a Marker of Anthracycline Cardiotoxicity?
    Muneer K; Jose B; Dubey G; T A; Cg S; Mn K
    Eur J Breast Health; 2022 Oct; 18(4):299-305. PubMed ID: 36248753
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EVALUATION OF 5-FLUOROURACIL-INDUCED CARDIOTOXICITY: ROLE OF CARDIAC BIOMARKERS.
    Moghaddam Z; Rostami M; Zeraatchi A; Abadi H; Karamitanha F; Amirmoghaddami H
    Exp Oncol; 2022 May; 44(1):60-66. PubMed ID: 35548958
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coenzyme complex decreased cardiotoxicity when combined with chemotherapy in treating elderly patients with gastrointestinal cancer.
    Zhang HY; Lu X
    Asian Pac J Cancer Prev; 2015; 16(9):4045-9. PubMed ID: 25987084
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Electrocardiographic Characteristics of Breast Cancer Patients Treated with Chemotherapy.
    Liang X; Wang Y; Yin X; Gong X; Pan S; Chen Z; Geng X
    Cardiol Res Pract; 2020; 2020():6678503. PubMed ID: 33376602
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antitumor chemotherapy after fluorouracil angina.
    Beretta G; Labianca R; Montinari F; Luporini G
    J Cancer Res Clin Oncol; 1982; 104(3):321-2. PubMed ID: 7161314
    [No Abstract]   [Full Text] [Related]  

  • 67. Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy.
    Chen ZL; Jia KP; Zheng Y; Zhang N; Wang X; Tse G; Zhang ZW; Hu HL; Liu T
    Ann Noninvasive Electrocardiol; 2024 Jan; 29(1):e13107. PubMed ID: 38288514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiogenic shock after 5-fluorouracil administration: a case report and literature review.
    Vanoverbeke L; Wouter H; François D; Ivan E
    Eur Heart J Case Rep; 2023 Dec; 7(12):ytad596. PubMed ID: 38099075
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis.
    Lu Y; Pan W; Deng S; Dou Q; Wang X; An Q; Wang X; Ji H; Hei Y; Chen Y; Yang J; Zhang HM
    Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111268
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise.
    Lestuzzi C; Stolfo D; De Paoli A; Banzato A; Buonadonna A; Bidoli E; Tartuferi L; Viel E; De Angelis G; Lonardi S; Innocente R; Berretta M; Bergamo F; Guglielmi A; Sinagra G; Herrmann J
    Oncologist; 2022 Mar; 27(2):e158-e167. PubMed ID: 35641220
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment.
    Anaka M; Abdel-Rahman O
    Cancer Manag Res; 2022; 14():273-285. PubMed ID: 35115827
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission.
    Montisci A; Palmieri V; Liu JE; Vietri MT; Cirri S; Donatelli F; Napoli C
    Front Cardiovasc Med; 2021; 8():713694. PubMed ID: 34540917
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 5-FU Cardiotoxicity: Vasospasm, Myocarditis, and Sudden Death.
    More LA; Lane S; Asnani A
    Curr Cardiol Rep; 2021 Feb; 23(3):17. PubMed ID: 33537861
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fluoropyrimidine-induced cardiotoxicity.
    Deac AL; Burz CC; Bocsan IC; Buzoianu AD
    World J Clin Oncol; 2020 Dec; 11(12):1008-1017. PubMed ID: 33437663
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.
    Dyhl-Polk A; Schou M; Vistisen KK; Sillesen AS; Serup-Hansen E; Faber J; Klausen TW; Bojesen SE; Vaage-Nilsen M; Nielsen DL
    Oncologist; 2021 Mar; 26(3):e403-e413. PubMed ID: 32959474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.
    Groehs RV; Negrao MV; Hajjar LA; Jordão CP; Carvalho BP; Toschi-Dias E; Andrade AC; Hodas FP; Alves MJNN; Sarmento AO; Testa L; Hoff PMG; Negrao CE; Filho RK
    Oncologist; 2020 Dec; 25(12):e1956-e1967. PubMed ID: 32762143
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines.
    Shiga T; Hiraide M
    Curr Treat Options Oncol; 2020 Mar; 21(4):27. PubMed ID: 32266582
    [TBL] [Abstract][Full Text] [Related]  

  • 78. QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics.
    Chandrasekhar S; Fradley MG
    Curr Treat Options Oncol; 2019 May; 20(7):55. PubMed ID: 31129799
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report.
    Hayasaka K; Takigawa M; Takahashi A; Kuwahara T; Okubo K; Tanaka Y; Misawa T; Mizusawa M; Yamakami Y; Kojima K; Sagawa Y; Hishikari K; Yamao K; Nakashima E; Nakajima J; Kimura S; Takagi K; Hikita H; Isobe M
    J Cardiol Cases; 2017 Jul; 16(1):26-29. PubMed ID: 30279790
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.